摘要
经皮冠状动脉介入治疗(PCI)已成为冠心病治疗及急性心肌梗死(AMI)血运重建的有效手段。取得令人满意的效果,而被临床广泛接受和应用。在冠心病患者中糖代谢异常发生率显著高于一般人群。有研究显示高血糖是引起冠状动脉支架再狭窄的独立危险因素。因此糖尿病患者PCI术后必须进行严格的血糖管理。根据目前研究结果,可能血糖目标定为餐前血糖<7.8mmol/L,且随机血糖<10.0mmol/L较为合适。
Percutaneous coronary intervention （PCI} has become effective means of treatment of coronary heart disease and AMI revascularization, make the satisfactory effect, and is widely accepted and used clinically. The metabolic abnormalities of sugar incidence are significantly higher than the general population in the patients who also have coronary artery disease. Research shows that hyperglycemia is independent risk factor of coronary stenting restenosis. Therefore diabetes PCI postoperative blood glucose management must be strictly. According to the current findings, goal as pre-dinner glucose is less than 7.8 mmol/L and random glucose 10.0 mmol/L ,which is relatively appropriate.
出处
《医学与哲学（B）》
2010年第11期8-10,共3页
Medicine & Philosophy(B)
关键词
PCI
冠心病
AMI
糖尿病
血糖管理
PCI, coronary heart disease, AMI, diabetes, glucose management
